Cellebrite Di LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Form 4: Cellebrite DI CEO Sells Shares
Thomas E. Hogan, Chief Executive Officer and a Director of Cellebrite DI Ltd., sold 139,713 shares of common stock on August 11, 2026 for $15.39 per share.
NASDAQ
Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd., sold 411 shares of common stock on August 12, 2026 for $16.07 per share.
NASDAQ
David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., sold 230 shares of common stock on August 12, 2026 for $16.07 per share.
NASDAQ
Cellebrite's Chief Financial Officer, David Barter, disposed of 41,734 ordinary shares to cover tax obligations related to vested restricted stock units.
NASDAQ
Cellebrite CEO Thomas E. Hogan reported the sale of 103,188 ordinary shares to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Cellebrite Chief Marketing Officer David Gee sold company shares to cover tax liabilities related to vested restricted stock units, as disclosed in a Form 4 filing.
NASDAQ
Cellebrite's Global Chief Revenue Officer, Marcus Jewell, reported the disposition of 12,658 ordinary shares to cover tax withholding obligations related to vested restricted stock units.
NASDAQ
Cellebrite's Chief Marketing Officer, David Gee, reported the sale of 228 ordinary shares to cover tax obligations related to vested restricted stock units.